An Ebola virus particle can be up to 14 micrometers long, or roughly five times smaller than the width of a human hair.

Scientists recently published findings indicating that Ebola virus creates and uses intercellular tunnels to move from cell to cell and evade treatments.

A new study investigates how the most abundant protein that composes the Ebola virus, VP 40, mediates replication of a new viral particle. The long-term objective of the research is to apply ...

Colorized transmission electron microscopic image showing the filamentous and curved morphology of an Ebola virus particle. [CDC/ Frederick A. Murphy] Researchers at the University of Iowa (UI ...

The latest Ebola outbreak has dwarfed any that have occurred since the discovery of the virus in 1976; previous outbreaks have had lethality rates of up to 90 percent. Yet no vaccines or therapies ...

This is the generation time of the virus—the time it takes for a particle of Ebola to get inside a human cell and potentially create thousands of identical copies of itself in the cell.

Scientists are trying to develop a more practical and affordable treatment for Ebola. According to a new study, an experiment on monkeys has shown that Ebola can be cured with just a pill.

In essence, Ebola VP40 is assembling on phosphatidylserine-enriched regions of human cells to form the long filamentous virus particle we are so familiar with seeing." ...

Scientists at Scripps Research have unveiled a new Ebola virus vaccine design, which they say has several advantages over standard vaccine approaches for Ebola and related viruses that continue to ...

The researchers then focused on bat species whose NPC1 proteins bind strongly to the Ebola virus glycoprotein and live in regions where previous Ebola outbreaks have occurred. This helps narrow down ...

Monkeys infected with Ebola can be cured with a pill, according to a new study out Friday that could pave the way for more practical, affordable treatments in humans. A day after exposure, ten ...

Ceres Nanosciences Inc. (Ceres) today announced the commencement of a development program, funded by the Gates Foundation, to use Ceres' Nanotrap particle technology to develop a new method of ...